Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 16, 2012 07:30 ET | Source: Lisata Therapeutics

NeoStem's Subsidiary, Progenitor Cell Therapy, and SOTIO Enter Into a Phase 3 Manufacturing Services Agreement

ALLENDALE, N.J. and WILMINGTON, Del., July 16, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) and its subsidiary, Progenitor Cell Therapy, LLC ("PCT"), an internationally recognized Contract...
July 10, 2012 07:30 ET | Source: Lisata Therapeutics

NeoStem to Present at the Seventh Annual JMP Securities Healthcare Conference

NEW YORK, July 10, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), a cell therapy company, today announced that its CEO will present at the Seventh Annual JMP...
July 09, 2012 07:30 ET | Source: Lisata Therapeutics

NeoStem CEO's Letter to Shareholders

NEW YORK, July 9, 2012 (GLOBE NEWSWIRE) -- Dear NeoStem Shareholders, NeoStem (NYSE MKT:NBS) is rapidly emerging as a technology and market leading company in the fast developing cell therapy...
June 25, 2012 07:54 ET | Source: Lisata Therapeutics

NeoStem Awarded NIAID Research Grant for the Development of VSEL Technology for Radiation Exposure

NEW YORK, June 25, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), a cell therapy company, today announced that it has been awarded a two year grant totaling...
June 20, 2012 08:36 ET | Source: Lisata Therapeutics

NeoStem Announces Webcasting for the Marcum MicroCap Conference on June 20

NEW YORK, June 20, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company focused on cell based therapies, today announced a...
June 18, 2012 07:00 ET | Source: Lisata Therapeutics

NeoStem Signs a Definitive Agreement to Divest Its 51% Ownership Interest in Suzhou Erye

NEW YORK, June 18, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company") today announced that the Company has entered into a definitive agreement to sell its 51% interest...
May 31, 2012 07:31 ET | Source: Lisata Therapeutics

NeoStem to Present at Six Conferences in June

NEW YORK, May 31, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company focused on cell based therapies, announced today that...
May 11, 2012 18:00 ET | Source: Lisata Therapeutics

NeoStem Reports First Quarter 2012 Results and Provides Business Update

NEW YORK, May 11, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company"), an international biopharmaceutical company focused on cell based therapies, today announced first...
April 18, 2012 08:21 ET | Source: Lisata Therapeutics

NeoStem to Present at BioCentury Future Leaders in the Biotech Industry Conference

NEW YORK, April 18, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or the "Company"), today announced that Company management will present an overview of the Company at the Future...
April 11, 2012 09:15 ET | Source: Lisata Therapeutics

NeoStem Announces the Addition of Jonathan Sackner-Bernstein, MD, Past FDA Official, as Vice President, Clinical Development and Regulatory Affairs

NEW YORK, April 11, 2012 (GLOBE NEWSWIRE) -- NeoStem, Inc. (NYSE Amex:NBS) ("NeoStem" or "the Company"), a leader in the cell therapy industry, is pleased to announce that Jonathan Sackner-Bernstein,...